Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • Alfa Wassermann, Norgine sales and marketing update

    Alfa Wassermann S.p.A., Bologna, Italy Norgine B.V., Amsterdam, the Netherlands Business: Hepatic The U.K.s NICE issued final guidance recommending 550 mg Targaxan rifaximin from Norgine to prevent recurrence of …

    Published on 3/30/2015
  • Bayer A sales and marketing update

    Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Cardiovascular The U.K.s NICE issued final guidance recommending use of Xarelto rivaroxaban from Bayer in combination with aspirin plus clopidogrel or aspirin alone …

    Published on 3/30/2015
  • Boehringer Ingelheim, Eli Lilly sales and marketing update

    Boehringer Ingelheim GmbH, Ingelheim, Germany Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Endocrine/Metabolic The U.K.s NICE issued final guidance recommending Jardiance empagliflozin from Boehringer …

    Published on 3/30/2015
  • Celgene Corp sales and marketing update

    Celgene Corp. (NASDAQ:CELG), Summit, N.J. Business: Cancer The U.K.s NICE issued final guidance recommending against use of Imnovid pomalidomide from Celgene in combination with dexamethasone to treat relapsed and …

    Published on 3/30/2015
  • Eisai sales and marketing update

    Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Business: Cancer Eisais Eisai Inc. subsidiary launched Lenvima lenvatinib in the U.S. to treat progressive, differentiated thyroid cancer in patients whose disease progressed …

    Published on 3/23/2015
  • Exact Sciences, Aetna sales and marketing update

    Exact Sciences Corp. (NASDAQ:EXAS), Madison, Wis. Aetna Inc. (NYSE:AET), Hartford, Conn. Business: Cancer Aetna will cover Exacts Cologuard to diagnose colon cancer, effective for three years starting April 1. Cologuard…

    Published on 3/23/2015
  • Vertex sales and marketing update

    Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Boston, Mass. Business: Pulmonary On Dec. 1, 2014, Vertexs Kalydeco ivacaftor was listed on the Australian Pharmaceutical Benefits Scheme (PBS) under a pay for performance …

    Published on 3/23/2015
  • Chugai sales and marketing update

    Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Business: Cancer Chugai launched Zelboraf vemurafenib in Japan to treat unresectable melanoma with a BRAF mutation. The mutation is identified using the cobas …

    Published on 3/16/2015
  • Eisai sales and marketing update

    Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Business: Cancer Eisai said the Cancer Drugs Fund (CDF) panel upheld an appeal from the company to reconsider a January decision from NHS England to remove breast cancer drug …

    Published on 3/16/2015
  • Meridian Bioscience sales and marketing update

    Meridian Bioscience Inc. (NASDAQ:VIVO), Cincinnati, Ohio Business: Diagnostic Meridian launched the TRU Strep Pneumo assay in Europe, the Middle East and Africa to detect Streptococcus pneumoniae in urine and …

    Published on 3/16/2015
  • Otsuka Pharmaceutical, Takeda sales and marketing update

    Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Gastrointestinal Takeda and Otsuka launched Takecab vonoprazan fumarate in Japan to treat acid-related …

    Published on 3/16/2015
  • CombiMatrix, Fortified Provider Network sales and marketing update

    CombiMatrix Corp. (NASDAQ:CBMX), Irvine, Calif. Fortified Provider Network Inc., Scottsdale, Ariz. Business: Diagnostic Fortified Provider Network (FPN) will cover CombiMatrixs diagnostic laboratory services. FPN has …

    Published on 3/9/2015
  • Ferring sales and marketing update

    Ferring Pharmaceuticals A/S, Saint-Prex, Switzerland Business: Autoimmune Ferring launched Cortiment MMX budesonide in Europe to treat adults with active mild to moderate ulcerative colitis in cases where mesalazine has…

    Published on 3/9/2015
  • Intas Pharmaceuticals sales and marketing update

    Intas Pharmaceuticals Ltd., Ahmedabad, India Business: Hematology, Biosimilars Intas Accord Healthcare subsidiary launched Accofil, a biosimilar of neutropenia drug Neupogen filgrastim, in the EU. Filgrastim is a …

    Published on 3/9/2015
  • Pacira sales and marketing update

    Pacira Pharmaceuticals Inc. (NASDAQ:PCRX), Parsippany, N.J. Business: Neurology Pacira said it resolved a warning letter from FDAs Office of Prescription Drug Promotion dated Sept. 25, 2014, regarding educational …

    Published on 3/9/2015
  • Raptor, Clinigen Group sales and marketing update

    Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Novato, Calif. Clinigen Group plc (LSE:CLIN), Burton-on-Trent, U.K. Business: Renal Clinigen launched an international global access program outside of the U.S., Latin America …

    Published on 3/9/2015
  • Celltrion Inc sales and marketing update

    Celltrion Inc. (KOSDAQ:068270), Incheon, South Korea Business: Autoimmune, Biosimilars Celltrion launched Remsima infliximab, a biosimilar of Remicade from Johnson & Johnson (NYSE:JNJ, New Brunswick, N.J.) and Merck & …

    Published on 3/2/2015
  • AbbVie Inc, Gilead, GKV-Spitzenverband sales and marketing update

    AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. GKV-Spitzenverband, Berlin, Germany Business: Infectious Germanys statutory health insurer GKV-Spitzenverband said Gilead …

    Published on 2/23/2015
  • Hisamitsu Pharmaceutical Co. Inc sales and marketing update

    Hisamitsu Pharmaceutical Co. Inc. (Tokyo:4530), Tosu, Japan Business: Musculoskeletal, Drug delivery Hisamitsus Noven Pharmaceuticals Inc. subsidiary launched 0.025 mg/day Minivelle estradiol transdermal system in the U…

    Published on 2/23/2015
  • Hospira Inc sales and marketing update

    Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Business: Autoimmune, Biosimilars Hospira launched Inflectra infliximab in major European markets, including Austria, Denmark, France, Germany, Greece, Italy, Luxembourg, the …

    Published on 2/23/2015
  • MannKind Corp, Sanofi sales and marketing update

    MannKind Corp. (NASDAQ:MNKD), Valencia, Calif. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Endocrine/Metabolic, Drug delivery Sanofi launched Afrezza in the U.S. to treat adults with Type I and II diabetes.…

    Published on 2/23/2015
  • Octapharma sales and marketing update

    Octapharma AG, Lachen, Switzerland Business: Hematology Octapharmas Octapharma USA subsidiary launched a co-pay assistance program for commercially insured patients taking wilate for von Willebrands Disease (VWD). The …

    Published on 2/23/2015
  • AstraZeneca, Clinigen Group sales and marketing update

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Clinigen Group plc (LSE:CLIN), Burton-on-Trent, U.K. Business: Infectious Clinigen launched an international global access program for AstraZenecas CAZ-AVI. CAZ-AVI is a…

    Published on 2/16/2015
  • Cynvenio Biosystems sales and marketing update

    Cynvenio Biosystems Inc., Westlake Village, Calif. Business: Diagnostic Cynvenio is launching its LiquidBiopsy platform in the U.S. this month. LiquidBiopsy uses a blood sample to perform sequence analysis and genomic …

    Published on 2/16/2015
  • Daiichi Sankyo sales and marketing update

    Daiichi Sankyo Co. Ltd. (Tokyo:4568), Tokyo, Japan Business: Cardiovascular Daiichi launched once-daily oral Savaysa edoxaban in the U.S. to reduce the risk of stroke and systemic embolism in patients with non-valvular…

    Published on 2/16/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993